Biotech pullback and RNN’s prospects

By westcoaster, March 26, 2014

This is a discussion topic or guest posting submitted by a Stock Gumshoe reader. The content has not been edited or reviewed by Stock Gumshoe, and any opinions expressed are those of the author alone.

I’m still holding my position in RNN despite the drop over the past week. I know there are quite a few Irregulars who own this stock, and I’d be grateful for any thoughts on where they think RNN is heading. Nothing fundamental has changed at the company; I think it’s just getting clobbered by the general biotech carnage.

Leave a Reply

6 Comments on " Biotech pullback and RNN’s prospects"

avatar

sjackson
Member
0
March 27, 2014 12:44 am

Paul: I believe that you are absolutely correct in your comments. This seems like a buying opportunity to me. I may add shares to my existing position.

lskulow
Irregular
66
lskulow
April 2, 2014 3:59 pm

RNN up .15 today! Hopefully, it will continue..
Press Release out today
http://investors.rexahn.com/releasedetail.cfm?ReleaseID=837198

robinsteel
Member
6
May 13, 2014 4:34 pm

Won Jun Choi et. al. Fluorocyclopentenyl-cytosine with Broad Spectrum and Potent Antitumor Activity. Journal of Medicinal Chemistry. 2012 (55): 4521-4525

THIS IS A LINK THAT WILL REASSURE EARLY INVESTORS….
but the race is on and it looks as if “The Market” will crash before the clinical studies are completed.
So our dilemma is whether or not to buy or sell now…or wait…

omcdac1
Guest
0
om
May 13, 2014 5:11 pm

i am long RNN.

wpDiscuz